Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Primary sacral non-germinal center type diffuse large B-cell lymphoma with MYC translocation: a case report and a review of the literature.

Shimada A, Sugimoto KJ, Wakabayashi M, Imai H, Sekiguchi Y, Nakamura N, Sawada T, Ota Y, Komatsu N, Noguchi M.

Int J Clin Exp Pathol. 2013 Aug 15;6(9):1919-28. Review.

2.

BCL2 positive and BCL6 negative diffuse large B cell lymphoma patients benefit from R-CHOP therapy irrespective of germinal and non germinal center B cell like subtypes.

Jovanovic MP, Mihaljevic B, Jakovic L, Martinovic VC, Fekete MD, Andjelic B, Antic D, Bogdanovic A, Boricic N, Terzic T, Jelicic J, Milenkovic S.

J BUON. 2015 May-Jun;20(3):820-8.

PMID:
26214636
3.

Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome.

Gualco G, Weiss LM, Harrington WJ Jr, Bacchi CE.

Am J Surg Pathol. 2009 Dec;33(12):1815-22. doi: 10.1097/PAS.0b013e3181bb9a18.

4.

Diffuse large B-cell lymphoma presenting as a sacral tumor. Report of two cases.

Liu JK, Kan P, Schmidt MH.

Neurosurg Focus. 2003 Aug 15;15(2):E10.

PMID:
15350041
5.

Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.

Wang W, Hu S, Lu X, Young KH, Medeiros LJ.

Am J Surg Pathol. 2015 Aug;39(8):1132-9. doi: 10.1097/PAS.0000000000000434.

PMID:
25828391
6.

Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study.

Tzankov A, Leu N, Muenst S, Juskevicius D, Klingbiel D, Mamot C, Dirnhofer S.

J Hematol Oncol. 2015 Jun 14;8:70. doi: 10.1186/s13045-015-0168-7.

7.

MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified.

Yan LX, Liu YH, Luo DL, Zhang F, Cheng Y, Luo XL, Xu J, Cheng J, Zhuang HG.

PLoS One. 2014 Aug 4;9(8):e104068. doi: 10.1371/journal.pone.0104068. Erratum in: PLoS One. 2014;9(10):e110724.

8.

Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.

Ozsan N, Cagirgan S, Saydam G, Gunes A, Hekimgil M.

Pathol Res Pract. 2013 Aug;209(8):471-8. doi: 10.1016/j.prp.2013.04.014.

PMID:
23726928
9.

Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.

Copie-Bergman C, Gaulard P, Leroy K, Briere J, Baia M, Jais JP, Salles GA, Berger F, Haioun C, Tilly H, Emile JF, Banham AH, Mounier N, Gisselbrecht C, Feugier P, Coiffier B, Molina TJ.

J Clin Oncol. 2009 Nov 20;27(33):5573-9. doi: 10.1200/JCO.2009.22.7058.

PMID:
19786664
10.

Diffuse large B-cell lymphoma with MYC gene rearrangements: Current perspective on treatment of diffuse large B-cell lymphoma with MYC gene rearrangements; case series and review of the literature.

de Jonge AV, Roosma TJ, Houtenbos I, Vasmel WL, van de Hem K, de Boer JP, van Maanen T, Lindauer-van der Werf G, Beeker A, Timmers GJ, Schaar CG, Soesan M, Poddighe PJ, de Jong D, Chamuleau ME.

Eur J Cancer. 2016 Mar;55:140-6. doi: 10.1016/j.ejca.2015.12.001. Review.

PMID:
26820684
11.

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

Green TM, Young KH, Visco C, Xu-Monette ZY, Orazi A, Go RS, Nielsen O, Gadeberg OV, Mourits-Andersen T, Frederiksen M, Pedersen LM, Møller MB.

J Clin Oncol. 2012 Oct 1;30(28):3460-7.

PMID:
22665537
12.

Endoscopic appearance of AIDS-related gastrointestinal lymphoma with c-MYC rearrangements: case report and literature review.

Tanaka S, Nagata N, Mine S, Igari T, Kobayashi T, Sugihara J, Honda H, Teruya K, Kikuchi Y, Oka S, Uemura N.

World J Gastroenterol. 2013 Aug 7;19(29):4827-31. doi: 10.3748/wjg.v19.i29.4827. Review.

13.

MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.

Yoon SO, Jeon YK, Paik JH, Kim WY, Kim YA, Kim JE, Kim CW.

Histopathology. 2008 Aug;53(2):205-17. doi: 10.1111/j.1365-2559.2008.03076.x.

PMID:
18752503
14.

Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases.

Agarwal R, Lade S, Liew D, Rogers TM, Byrne D, Feleppa F, Juneja S, Westerman DA.

J Clin Pathol. 2016 Mar;69(3):266-70. doi: 10.1136/jclinpath-2015-203002.

PMID:
26307073
15.

T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.

Gualco G, Weiss LM, Barber GN, Bacchi CE.

Hum Pathol. 2010 Sep;41(9):1238-44. doi: 10.1016/j.humpath.2010.01.015.

PMID:
20382409
17.

[Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children].

Yang WP, Zhu CD, Gong LP, Lü BB, Zou Y, Zhong HS, Xiao Q, Wu Y, Xu HY, Zeng ST, Huang H.

Zhonghua Bing Li Xue Za Zhi. 2009 Nov;38(11):759-64. Chinese.

PMID:
20079016
18.

C-MYC overexpression predicts aggressive transformation and a poor outcome in mucosa-associated lymphoid tissue lymphomas.

Huang W, Guo L, Liu H, Zheng B, Ying J, Lv N.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):5634-44.

19.

Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

Xu-Monette ZY, Dabaja BS, Wang X, Tu M, Manyam GC, Tzankov A, Xia Y, Zhang L, Sun R, Visco C, Dybkaer K, Yin L, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Møller MB, Parsons BM, Zhao X, Winter JN, Piris MA, McDonnell TJ, Miranda RN, Li Y, Medeiros LJ, Young KH.

Mod Pathol. 2015 Dec;28(12):1555-73. doi: 10.1038/modpathol.2015.118.

20.

[Immunophenotyping and molecular genetic analysis of diffuse large B-cell lymphoma].

Han YS, Xue YQ, Yang HY, Zhang J, Pan JL.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Apr;30(2):143-7. doi: 10.3760/cma.j.issn.1003-9406.2013.04.004. Chinese.

PMID:
23568722

Supplemental Content

Support Center